Economic evaluation of early screening for diabetic retinopathy using fundus photography;Évaluation économique a priori du dépistage de la rétinopathie diabétique par photographies du fond d'œil

Journal d'Economie Medicale

Volumn 30, Issue 2, 2012, Pages 79-95

  Launois, R ^a   Le Moine, J G ^a   Raimond, V ^b   Maunoury, F ^a   Daher, I ^a   Akindele M ^a   Dessaigne, A ^b  

^a Haute Autorité de Santé ^*  (France)

^b Ancien Délégué Général de la Fédération de l'Hospitalisation Privée   (France)

Author keywords

Closed multi cohort model; Diabetic retinopathy; Population screening

Indexed keywords

EID: 84865184592     PISSN: 02940736     EISSN: None     Source Type: Journal    
DOI: 10.3917/jgem.122.0079     Document Type: Article

References (26)

1. Kusnik-Joinville O, Weill A, Salavane B. Diabète traité : quelles évolutions entre 2000 et 2005 ? Prat Organ Soins. 2007;38(1): 1-12.
2. Porta M, Bandello F. Diabetic retinopathyA clinical update. Diabetologia. Dec 2002;45(12): 1617-1634.
3. Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy. Invest Ophthalmol Vis Sci. Jul 1981; 21 (1 Pt 2): 1-226.
4. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. Dec 1985; 103(12): 1796-1806.
5. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. May 1991 ;98(5 Suppl):766-785.
6. HAS. Recommandations en santé publique. Argumentaire. Dépistage de la rétinopathie diabétique par lecture différée de photographies du fond d'oeil. Paris: Haute Autorité de Santé;2011.
7. Launois R, Croutsche JJ, Menigbeto A, Le Lay K. L'apport indispensable de l 'épidémiologie clinique aux modèles de Markov. Journal d 'Economie Médicale. 1999; 17(5):343-361. (Pubitemid 29484734)
8. Younis N, Broadbent DM, Harding SP, Vora JR. Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme. Diabet Med. Dec 2002; 19(12): 1014-1021. (Pubitemid 35471971)
9. Younis N, Broadbent DM, Harding SP, Vora JP. Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme. Diabet Med. Sep 2003;20(9):758-765. (Pubitemid 41701472)
10. Baeza M, Orozco-Beltran D, Gil-Guillen VF, et al. Screening for sight threatening diabetic retinopathy using non-mydriatic retinal camera in a primary care setting: to dilate or not to dilate? Int J Clin Pract. Mar 2009;63(3):433-438.
11. Scanlon PH, Malhotra R, Greenwood RH, et al. Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy. Br J Ophthalmol. Oct 2003 ;87( 10): 1258-1263. (Pubitemid 37193918)
12. Moss SE, Klein R, Kessler SD, Richie KA. Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology. Jan 1985;92 (1):62-67. (Pubitemid 15170415)
13. Clinical Guidelines for type 2 diabetes. London: Royal College of General Practioners;2005.
14. Weinstein MC. Clinical decision analysis. Philadelphia: Saunders; 1980.
15. Briggs AH, Claxton K, Sculpher MJ. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006.
16. Hove MN, Kristensen JK, Lauritzen T, Bek T. The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark. Acta Ophthalmol Scand. Aug 2004;82(4):443-448. (Pubitemid 39199446)
17. Tucker D, Rouscoulp M, Girach A. Investigating the links between retinopathy, macular oedema and visual acuity with diabetes. Expert Rev Ophtalmol. 2008;3(6):673-688.
18. ENTRED. Etude ENTRED : suite des résultats. Les complications du diabète et le diabète du sujet agé, Bulletin épidémiologique hebdomadaire. Paris: ENTRED;2005.
19. Vijan S, Hofer TP, Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA. Feb 16 2000;283(7):889-896. (Pubitemid 30102129)
20. CNAMTS. Les associations d'acte CCAM en 2008. Points de repère. 2010;29.
21. Le point sur les cotations. Revue française d'ophtalmologie. 2009; 168.
22. Lebègue D. Révision du taux d 'actualisation des investissements publics. Paris: La documentation française;2005.
23. Launois R. Exemple d 'étude médico-economique: le dépistage du cancer de la prostate In: Sancho-Garnier, ed. Dépistage des cancers. Paris: Editions INSERM 1997:57-70.
24. Launois R. Les Arcanes décryptées de l'analyse médico économique à l'usage du décideur. Journal d 'Économie Médicale. 2008;26(6-7):331-349.
25. Launois R, Payet S, Saidenberg-Kermanac'h N, Francesconi C, Franca LR, Boissier MC. Budget impact model of rituximab after failure of one or more TNFalpha inhibitor therapies in the treatment of rheumatoid arthritis. Joint Bone Spine. Dec 2008;75(6):688-695.
26. Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. Apr 2001 ;20(3 Suppl):21-35. (Pubitemid 33732964)